爱游戏平台注册登录

AlphaLISA Binding Kits

OF

蛋白質相互作用和結合穿插在大量的生物過程中。高效,高靈敏度研究大蛋白質相互作用的檢測需求變得日益重要。Alpha技術作為一種高度靈活,均勻,免洗方法,非常適合測量蛋白質之間相互作用和大小接近200納米的複合物。基於微珠的親近均相測定,Alpha 技術提供了測定許多生物靶標的可能性,包括酶,受體 - 配體相互作用,低親和力相互作用,第二信使水平,DNA,RNA,蛋白質,肽,糖和小分子。

檢測特點及優勢特點:

  • 免洗步驟,無分離步驟
  • 易用性:少量加樣步驟,快速分析開發
  • 廣泛的親和力:檢測強或弱的相互作用,從pM到mM親和力
  • 距離:測量非常大的蛋白質或抗體複合物 - 跨越200nm或更多
  • 高親合力:每個珠子上的多個結合位點能夠使用納摩爾濃度的抗體或蛋白質,以及使用低親和力結合劑

產品與服務 (36)
Filters:

篩選條件

全部展開 全部折疊
檢測目標
  • 4-1BB (1)
  • 4-1BBL (1)
  • C1q (1)
  • CD28 (1)
  • CD80 (1)
  • CD86 (2)
  • Cereblon (1)
  • clAP1 BIR2 (1)
  • clAP1 BIR3 (1)
  • CTLA4 (2)
  • EGF (1)
  • EGFR (1)
  • FCGR1 (1)
  • FCGR2A (2)
  • FCGR2B (1)
  • FCGR3A (2)
  • HLA-DRA (1)
  • KRAS (4)
  • LAG3 (1)
  • LDLR (1)
  • MDM2 (1)
  • PCSK9 (1)
  • PD-1 (4)
  • PD-L1 (3)
  • PDGF-BB (2)
  • PDGFR (2)
  • PDL-1 (1)
  • SARS-CoV2 ACE2/S1 (1)
  • STING WT (1)
  • TNFα (2)
  • TNRFR1 (1)
  • TNRFR3 (1)
  • XIAP BIR2 (1)
  • XIAP BIR3 (1)
目標種
  • Human (11)
應用
  • Biologics/Bioprocess (6)
  • Protein Analysis & Detection (8)
  • Protein Binding (4)
  • Protein Detection (13)
  • Protein-protein interactions (18)
檢測目標類
  • Cytokine (2)
  • Fc-receptor (6)
  • Protein (15)
治療領域
  • Autoimmunity (4)
  • Cardiovascular (2)
  • Central Nervous System (1)
  • Immuno-oncology (5)
  • Infectious Disease (non-viral) (1)
  • Inflammation (3)
  • Metabolic (1)
  • Neuroscience (4)
  • Oncology (18)
  • Rare Diseases (1)
  • Respiratory (1)
  • Virology (2)

排序方式

1-25 的 36 產品與服務

  • AlphaLISA Human C1q Binding Kit

    The AlphaLISA® Human C1q Binding Kit is designed to monitor the binding of the IgG Fc region to the human C1q protein.

  • PROTAC binding assay kit

    AlphaLISA Human XIAP BIR3 Binding Kit

    The AlphaLISA® Human XIAP BIR3 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, XIAP BIR3 domain, using Alpha Technology.

  • PROTAC binding assay kit

    AlphaLISA Human XIAP BIR2 Binding Kit

    The AlphaLISA® Human XIAP BIR2 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, XIAP BIR2 domain, using Alpha Technology.

  • AlphaLISA assay technology

    AlphaLISA Human MDM2 Binding Kit

    The AlphaLISA® Human MDM2 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, MDM2, using Alpha Technology.

  • AlphaLISA assay technology

    AlphaLISA Human cIAP1 BIR3 Binding Kit

    The AlphaLISA® Human cIAP1 BIR3 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, cIAP1 BIR3 domain, using Alpha Technology.

  • AlphaLISA assay technology

    AlphaLISA Human cIAP1 BIR2 Binding Kit

    The AlphaLISA® Human cIAP1 BIR2 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, cIAP1 BIR2 domain, using Alpha Technology.

  • PROTAC binding assay kit

    AlphaLISA Human KRAS G12C/SOS1 Binding Kit

    The AlphaLISA® Human KRAS G12C/SOS1 Binding Kit is designed for the detection of binding activity between human KRAS G12C and SOS1, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to identify inhibitors of the KRAS G12C / SOS1 protein interaction.
  • PROTAC binding assay kit

    AlphaLISA Human KRAS WT/SOS1 Binding Kit

    The AlphaLISA® Human KRAS WT/SOS1 Binding Kit is designed for the detection of binding activity between human KRAS WT and SOS1, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This KRAS SOS1 assay kit can be used to identify inhibitors of KRAS WT / SOS1 protein interactions.
  • PROTAC binding assay kit

    AlphaLISA Human KRAS G12C GTP Binding Kit

    The AlphaLISA® Human KRAS G12C GTP Binding Kit is designed for the detection of binding activity between human KRAS G12C mutant and GTP, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to identify KRAS G12C/GTP inhibitors.
  • PROTAC binding assay kit

    AlphaLISA Human KRAS WT GTP Binding Kit

    The AlphaLISA® Human KRAS WT GTP Binding Kit is designed for the detection of binding activity between human KRAS wild type (WT) and GTP, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This KRAS GTP assay can be used to identify KRAS WT / GTP inhibitors.
  • PROTAC binding assay kit

    AlphaLISA Human Cereblon Binding Kit

    The AlphaLISA® Human Cereblon Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, Cereblon, using Alpha Technology.

  • PROTAC binding assay kit

    AlphaLISA SARS-CoV2 ACE2/S1 Binding Kit

    The AlphaLISA® SARS-CoV2 ACE2/S1 Binding Kit is a protein-protein interaction assay for ACE2-Spike inhibitor selection in biochemical format using Alpha Technology.

  • PROTAC binding assay kit

    STING WT AlphaLISA Binding Kit

    The AlphaLISA® STING WT Binding Kit is a sandwich immunoassay for quantitative detection of STING WT Binding in cellular lysates using Alpha Technology.
  • AlphaLISA HIV 1 p24 detection kit

    PD-1/PD-L1 (cyno) AlphaLISA Binding Kit

    The AlphaLISA® cyno PD-1/PD-L1 binding kit is designed for the detection of binding activity between cyno PD-1 and PD-L1, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.

  • AlphaLISA Binding

    PCSK9/LDLR (human) AlphaLISA Binding Kit

    This kit is designed to assess binding and inhibition of human PCSK9 and LDLR, using a homogeneous AlphaLISA assay (no wash steps). This assay can facilitate the design and development of antibody therapetics using competition assays.

    This is a replacement for AL3119.

  • AlphaLISA HIV 1 p24 detection kit

    CD28/CD86 (human) AlphaLISA Binding Kit

    The AlphaLISA® human CD28/CD86 binding kit is designed for the detection of binding activity between human CD28 and CD86, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.

  • AlphaLISA HIV 1 p24 detection kit

    PD-1/PD-L2 (human) AlphaLISA Binding Kit

    The AlphaLISA® human PD-1/PD-L2 binding kit is designed for the detection of binding activity between human PD-1 and PD-L2, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.
  • AlphaLISA Binding

    TNFα/TNFR2 (human) AlphaLISA Binding Kit

    The AlphaLISA® human TNFα/TNFR2 binding kit is designed for the detection of binding activity between human TNFα and TNFR2, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.
  • AlphaLISA Binding

    TNFα/TNFR1 (human) AlphaLISA Binding Kit

    The AlphaLISA® human TNFα/TNFR1 binding kit is designed for the detection of binding activity between human TNFα and TNFR1, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.
  • AlphaLISA Binding

    4-1BB/4-1BBL (human) AlphaLISA Binding Kit

    The AlphaLISA® 4-1BB/4-1BBL binding kit is designed for the detection of binding activity between human 4-1BB and 4-1BBL, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.
  • AlphaLISA HIV 1 p24 detection kit

    FcRn (human) AlphaLISA Binding Kit

    The AlphaLISA human FcRn binding kit is designed for the detection of binding between FcRn and human IgG using a homogeneous AlphaLISA assay (no wash steps). This assay can facilitate the design and development of antibody therapeutics using a competition assay format.
  • AlphaLISA HIV 1 p24 detection kit

    FcγR3B (CD16b) AlphaLISA Binding Kit

    The AlphaLISA FCGR3B (CD16b) binding kit is designed for the detection of binding between FcγR3B (CD16b) and human IgG Fc fragment using a homogeneous AlphaLISA assay (no wash steps). This assay can facilitate the design and development of antibody therapeutics using a competition assay format.
  • AlphaLISA Binding

    PD-1/PD-L1 (mouse) AlphaLISA Binding Kit

    AlphaLISA®小鼠PD-1/PD-L1結合技術可以在體外和體內研究中,幫助構建和表征小分子和大分子抗小鼠PD-1/PD-L1試劑。該試驗也可以測試其他可能的結合配體,例如PD-L2,或表征配體亞區阻礙結合的能力。並且,AlphaLISA®可以通過均相化試驗,測定抗人PD-1/PD-L1試劑的小鼠交叉反應性。(無洗脫步驟)
  • AlphaLISA HIV 1 p24 detection kit

    FcγR2A/CD32a (167R) AlphaLISA Binding Kit

    This kit is designed for the detection of binding between FCGR2A (CD32a) (167R) and human IgG Fc fragment using a homogeneous AlphaLISA® assay (no wash steps). This assay can facilitate the design and development of antibody therapeutics by using competitive binding.
  • AlphaLISA HIV 1 p24 detection kit

    FcγR2A/CD32a (167H) AlphaLISA Binding Kit

    This kit is designed for the detection of binding between FCGR2A (CD32a) (167H) and human IgG Fc fragment using a homogeneous AlphaLISA® assay (no wash steps). This assay can facilitate the design and development of antibody therapeutics by using competitive binding.
  • Jump to:
Baidu
map